Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone

A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory Neuropathy.

The journal of pain·2022

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.

PloS one·2015

Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy.

Journal of acquired immune deficiency syndromes (1999)·2014

Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

Clinical drug investigation·2014

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.

Antiviral therapy·2013

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity.

Antiviral therapy·2012

Effect of antiretroviral resistance on response in treatment-experienced patients.

The AIDS reader·2009

Maximizing treatment outcome: key considerations for antiretroviral-experienced patients.

The AIDS reader·2009

Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management.

The AIDS reader·2009

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

The AIDS reader·2009

Isolated unilateral acute retinal necrosis syndrome as the initial manifestation of HIV infection.

The AIDS reader·2009

Colitis and gastroparesis associated with syphilis in an HIV-infected person with an undetectable viral load.

The AIDS reader·2009

Chronic stable recording of physiologically evoked neural activity in a mixed autonomic nerve in awake, freely moving normal and experimental cystitis rats.

APL bioengineering·2026

Practical insights from implementing a national programme for monitoring appropriateness of antimicrobial prescribing in the South-East Asia Region: experience from the CAPTURA project in Bangladesh, Bhutan, and Nepal.

IJID regions·2026

Nocturnal heart rate variability in Parkinson's disease: associations with autonomic dysfunction, cognitive function, and mood symptoms.

Clinical parkinsonism & related disorders·2026

Astaxanthin exerts neuroprotection against experimental intracerebral hemorrhage in mice: association with anti-neuroinflammation and the Nrf2-ARE pathway.

Frontiers in neurology·2026

Antiviral strategies against human norovirus: Molecular targets, therapeutics, and vaccine development.

Therapeutic advances in infectious disease·2026

Neuroinflammation, HPA Axis Dysregulation, Cytokine Activity and Nutritional Modulation in Depression: A PRISMA-compliant Systematic Review.

Annals of neurosciences·2026

Related Experiment Videos

Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone

Related Concept Videos

A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory Neuropathy.

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals.

Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy.

Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naïve patients with HIV-1 infection.

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity.

Effect of antiretroviral resistance on response in treatment-experienced patients.

Maximizing treatment outcome: key considerations for antiretroviral-experienced patients.

Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management.

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

Isolated unilateral acute retinal necrosis syndrome as the initial manifestation of HIV infection.

Colitis and gastroparesis associated with syphilis in an HIV-infected person with an undetectable viral load.

Chronic stable recording of physiologically evoked neural activity in a mixed autonomic nerve in awake, freely moving normal and experimental cystitis rats.

Practical insights from implementing a national programme for monitoring appropriateness of antimicrobial prescribing in the South-East Asia Region: experience from the CAPTURA project in Bangladesh, Bhutan, and Nepal.

Nocturnal heart rate variability in Parkinson's disease: associations with autonomic dysfunction, cognitive function, and mood symptoms.

Astaxanthin exerts neuroprotection against experimental intracerebral hemorrhage in mice: association with anti-neuroinflammation and the Nrf2-ARE pathway.

Antiviral strategies against human norovirus: Molecular targets, therapeutics, and vaccine development.

Neuroinflammation, HPA Axis Dysregulation, Cytokine Activity and Nutritional Modulation in Depression: A PRISMA-compliant Systematic Review.

Related Experiment Videos

Abacavir plus lamivudine: a thymidine analogue-sparing NRTI backbone

Related Concept Videos

Related Articles